These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18608098)

  • 1. Medications and laboratory parameters as prognostic factors in amyotrophic lateral sclerosis.
    Qureshi M; Shui A; Dibernardo AB; Brown RH; Schoenfeld DA; Cudkowicz ME
    Amyotroph Lateral Scler; 2008 Dec; 9(6):369-74. PubMed ID: 18608098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history of ALS is changing: improved survival.
    Qureshi M; Schoenfeld DA; Paliwal Y; Shui A; Cudkowicz ME
    Amyotroph Lateral Scler; 2009; 10(5-6):324-31. PubMed ID: 19922119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].
    Liu XX; Fan DS; Zhang J; Zhang S; Zheng JY
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2472-5. PubMed ID: 20137433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional outcome measures as clinical trial endpoints in ALS.
    Traynor BJ; Zhang H; Shefner JM; Schoenfeld D; Cudkowicz ME;
    Neurology; 2004 Nov; 63(10):1933-5. PubMed ID: 15557515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis.
    Cudkowicz ME; Shefner JM; Schoenfeld DA; Brown RH; Johnson H; Qureshi M; Jacobs M; Rothstein JD; Appel SH; Pascuzzi RM; Heiman-Patterson TD; Donofrio PD; David WS; Russell JA; Tandan R; Pioro EP; Felice KJ; Rosenfeld J; Mandler RN; Sachs GM; Bradley WG; Raynor EM; Baquis GD; Belsh JM; Novella S; Goldstein J; Hulihan J;
    Neurology; 2003 Aug; 61(4):456-64. PubMed ID: 12939417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The amyotrophic lateral sclerosis functional rating scale predicts survival time in amyotrophic lateral sclerosis patients on invasive mechanical ventilation.
    Lo Coco D; Marchese S; La Bella V; Piccoli T; Lo Coco A
    Chest; 2007 Jul; 132(1):64-9. PubMed ID: 17475635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
    Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALS clinical trials: do enrolled patients accurately represent the ALS population?
    Chiò A; Canosa A; Gallo S; Cammarosano S; Moglia C; Fuda G; Calvo A; Mora G;
    Neurology; 2011 Oct; 77(15):1432-7. PubMed ID: 21956723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase angle is a prognostic factor for survival in amyotrophic lateral sclerosis.
    Desport JC; Marin B; Funalot B; Preux PM; Couratier P
    Amyotroph Lateral Scler; 2008 Oct; 9(5):273-8. PubMed ID: 18720089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ALSFRSr predicts survival time in an ALS clinic population.
    Kaufmann P; Levy G; Thompson JL; Delbene ML; Battista V; Gordon PH; Rowland LP; Levin B; Mitsumoto H
    Neurology; 2005 Jan; 64(1):38-43. PubMed ID: 15642901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALSFRS-R score and its ratio: a useful predictor for ALS-progression.
    Kollewe K; Mauss U; Krampfl K; Petri S; Dengler R; Mohammadi B
    J Neurol Sci; 2008 Dec; 275(1-2):69-73. PubMed ID: 18721928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The changes of clinical characteristics in 100 Japanese amyotrophic lateral sclerosis patients between 1980 and 2000].
    Kimura F; Shinoda K; Fujiwara S; Fujimura C; Nakajima H; Furutama D; Sugino M; Hanafusa T
    Rinsho Shinkeigaku; 2003 Jul; 43(7):385-91. PubMed ID: 14582363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized sequential trial of creatine in amyotrophic lateral sclerosis.
    Groeneveld GJ; Veldink JH; van der Tweel I; Kalmijn S; Beijer C; de Visser M; Wokke JH; Franssen H; van den Berg LH
    Ann Neurol; 2003 Apr; 53(4):437-45. PubMed ID: 12666111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-based effect of statins on functional decline in amyotrophic lateral sclerosis.
    Nefussy B; Hirsch J; Cudkowicz ME; Drory VE
    J Neurol Sci; 2011 Jan; 300(1-2):23-7. PubMed ID: 21056430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis?
    de Carvalho M; Swash M
    Arch Neurol; 2006 Apr; 63(4):557-60. PubMed ID: 16606769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phrenic nerve studies predict survival in amyotrophic lateral sclerosis.
    Pinto S; Pinto A; de Carvalho M
    Clin Neurophysiol; 2012 Dec; 123(12):2454-9. PubMed ID: 22762911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.
    Kimura F; Fujimura C; Ishida S; Nakajima H; Furutama D; Uehara H; Shinoda K; Sugino M; Hanafusa T
    Neurology; 2006 Jan; 66(2):265-7. PubMed ID: 16434671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and neurophysiological evaluation of progression in amyotrophic lateral sclerosis.
    de Carvalho M; Scotto M; Lopes A; Swash M
    Muscle Nerve; 2003 Nov; 28(5):630-3. PubMed ID: 14571468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of quality of life in ALS: Lessons from the minocycline study.
    Lou JS; Moore D; Gordon PH; Miller R
    Amyotroph Lateral Scler; 2010; 11(1-2):116-21. PubMed ID: 19551536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.